Clinical Trial Update: Ketamine Augmentation of ECT in Treatment-Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 study evaluating ketamine augmentation of electroconvulsive therapy for treatment-resistant major depressive disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Università Vita-Salute San Raffaele | Conditions: Major Depressive Disorder, Treatment Resistant Depression | Phase 3 | Status: RECRUITING